Literature DB >> 18446504

The pharmacokinetics and interactions of ivermectin in humans--a mini-review.

Aránzazu González Canga1, Ana M Sahagún Prieto, M José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega, Juan J García Vieitez.   

Abstract

Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wide margin of safety. Since 1987, this compound has a widespread use in veterinary medicine and it use has been extended in humans. Here we present a brief review of the information available regarding the pharmacokinetics and interactions of ivermectin in humans. Awareness of these characteristics could improve the clinical efficacy of Ivermectin. All Authors declare that they do not have any Conflict of interest and that the work is original. All Authors agree that the contents of the manuscript are confidential and will not be copyrighted, submitted, or published elsewhere (including the Internet), in any language, while acceptance by the Journal is under consideration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446504      PMCID: PMC2751445          DOI: 10.1208/s12248-007-9000-9

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  30 in total

1.  Merck's new drug free to WHO for river blindness programme.

Authors:  D Lindley
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

2.  The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.

Authors:  G Edwards; A Dingsdale; N Helsby; M L Orme; A M Breckenridge
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Ivermectin levels in human breastmilk.

Authors:  J E Ogbuokiri; B C Ozumba; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Pharmacokinetics and metabolism of avermectins in livestock.

Authors:  J W Steel
Journal:  Vet Parasitol       Date:  1993-06       Impact factor: 2.738

5.  Determination of ivermectin in human plasma by high-performance liquid chromatography.

Authors:  D R Krishna; U Klotz
Journal:  Arzneimittelforschung       Date:  1993-05

6.  Ivermectin binds avidly to plasma proteins.

Authors:  U Klotz; J E Ogbuokiri; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.

Authors:  K Awadzi; G Edwards; N O Opoku; A E Ardrey; S Favager; E T Addy; S K Attah; L K Yamuah; B T Quartey
Journal:  Ann Trop Med Parasitol       Date:  2004-09

8.  Protein binding and ivermectin estimations in patients with onchocerciasis.

Authors:  P O Okonkwo; J E Ogbuokiri; E Ofoegbu; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1993-04       Impact factor: 6.875

9.  Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus.

Authors:  M H Elkassaby
Journal:  Trop Med Parasitol       Date:  1991-06

10.  Coagulation abnormalities and ivermectin.

Authors:  J A Whitworth; C R Hay; A M McNicholas; D Morgan; G H Maude; D W Taylor
Journal:  Ann Trop Med Parasitol       Date:  1992-06
View more
  96 in total

1.  Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi.

Authors:  Yovany Moreno; Joseph F Nabhan; Jonathan Solomon; Charles D Mackenzie; Timothy G Geary
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 2.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

3.  Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of Mansonella ozzardi infection in the Brazilian Amazon.

Authors:  Sergio de Almeida Basano; Juliana de Souza Almeida Aranha Camargo; Gilberto Fontes; Antonieta Relvas Pereira; Jansen Fernandes Medeiros; Mayara Costa de Oliveira Laudisse; Ricardo de Godoi Mattos Ferreira; Luís Marcelo Aranha Camargo
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

4.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 5.  How do the macrocyclic lactones kill filarial nematode larvae?

Authors:  Adrian J Wolstenholme; Mary J Maclean; Ruby Coates; Ciaran J McCoy; Barbara J Reaves
Journal:  Invert Neurosci       Date:  2016-06-09

6.  Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.

Authors:  Urs Duthaler; Claudia Suenderhauf; Mats O Karlsson; Janine Hussner; Henriette Meyer Zu Schwabedissen; Stephan Krähenbühl; Felix Hammann
Journal:  Br J Clin Pharmacol       Date:  2019-01-24       Impact factor: 4.335

7.  Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte.

Authors:  Jason S Yang; Weipeng Qi; Renalison Farias-Pereira; Stephanie Choi; John M Clark; Daeyoung Kim; Yeonhwa Park
Journal:  Food Chem Toxicol       Date:  2019-02-06       Impact factor: 6.023

8.  Safe-in-Man Broad Spectrum Antiviral Agents.

Authors:  Rouan Yao; Aleksandr Ianevski; Denis Kainov
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.

Authors:  Robert T Kinobe; Leigh Owens
Journal:  Fundam Clin Pharmacol       Date:  2021-01-28       Impact factor: 2.748

10.  Toxicity and potential utility of ivermectin and moxidectin as xenointoxicants against the common bed bug, Cimex lectularius L.

Authors:  Johnathan M Sheele; Gale E Ridge
Journal:  Parasitol Res       Date:  2016-04-18       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.